Insider Selling: Liquidia (NASDAQ:LQDA) Insider Sells 688 Shares of Stock

by · The Cerbat Gem

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) insider Jason Adair sold 688 shares of the company’s stock in a transaction on Monday, January 26th. The shares were sold at an average price of $41.65, for a total transaction of $28,655.20. Following the sale, the insider directly owned 211,169 shares in the company, valued at $8,795,188.85. This trade represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Jason Adair also recently made the following trade(s):

  • On Monday, January 12th, Jason Adair sold 13,548 shares of Liquidia stock. The shares were sold at an average price of $37.43, for a total value of $507,101.64.
  • On Monday, December 1st, Jason Adair sold 693 shares of Liquidia stock. The stock was sold at an average price of $32.19, for a total transaction of $22,307.67.
  • On Tuesday, November 18th, Jason Adair sold 35,656 shares of Liquidia stock. The stock was sold at an average price of $30.03, for a total transaction of $1,070,749.68.

Liquidia Price Performance

Shares of Liquidia stock traded down $0.56 during trading on Wednesday, hitting $41.91. 1,383,798 shares of the stock traded hands, compared to its average volume of 2,368,033. The firm’s fifty day moving average is $34.65 and its 200-day moving average is $27.49. Liquidia Corporation has a 52 week low of $11.26 and a 52 week high of $43.42. The stock has a market cap of $3.65 billion, a price-to-earnings ratio of -29.10, a PEG ratio of 1.18 and a beta of 0.48. The company has a quick ratio of 1.96, a current ratio of 2.20 and a debt-to-equity ratio of 6.19.

Liquidia (NASDAQ:LQDA – Get Free Report) last posted its earnings results on Monday, November 3rd. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.45) by $0.41. The firm had revenue of $54.34 million during the quarter, compared to analysts’ expectations of $18.86 million. Liquidia had a negative net margin of 176.04% and a negative return on equity of 296.78%. The firm’s quarterly revenue was up 1106.7% on a year-over-year basis. Research analysts expect that Liquidia Corporation will post -1.51 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on LQDA. BTIG Research reaffirmed a “buy” rating and issued a $49.00 price objective on shares of Liquidia in a research note on Friday, January 9th. Wall Street Zen lowered shares of Liquidia from a “buy” rating to a “hold” rating in a research note on Sunday, January 18th. Needham & Company LLC boosted their price target on shares of Liquidia from $36.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a report on Thursday, January 22nd. Finally, Zacks Research upgraded shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $39.67.

Check Out Our Latest Stock Analysis on Liquidia

Institutional Trading of Liquidia

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. NewEdge Advisors LLC bought a new position in Liquidia in the 2nd quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Liquidia in the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC purchased a new stake in shares of Liquidia during the third quarter worth $34,000. Steward Partners Investment Advisory LLC increased its stake in shares of Liquidia by 24.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock worth $77,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its position in shares of Liquidia by 281.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after purchasing an additional 4,927 shares during the period. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Featured Stories